Results 211 to 220 of about 2,071,977 (304)

On Eurasian Association of Cardiothoracic Surgeons - EAACTS

Heart Vessels and Transplantation, 2018
Jamalbek I. Ashimov, Taalaibek Z. Kudaiberdiev   +1 more
doaj   +1 more source

My heart will go on - quantitative content analysis of donor and donation images in patients after heart transplantation. [PDF]

Front Psychol
Wahlers L, Laskowski NM, Halbeisen G, Tigges-Limmer K, Paslakis G.   +4 more
europepmc   +1 more source

Outcomes of Patients With AL Amyloidosis and End‐Stage Renal Disease After Initiation of Therapy

American Journal of Hematology, EarlyView.
ABSTRACT In AL amyloidosis, advanced renal disease can impact treatment options and cause significant morbidity. Patients with ESRD requiring dialysis are a group with currently unmet needs. In this collaborative study, we identified 362 patients from three European centers who initiated dialysis during the course of the disease.
Foteini Theodorakakou, Lilli Sophie Sester, Ute Hegenbart, Paolo Milani, Claudia Bellofiore, Erasmia Psimenou, Charikleia Gakiopoulou, Meletios A. Dimopoulos, Giovanni Palladini, Stefan O. Schönland, Efstathios Kastritis   +10 more
wiley   +1 more source

Correction to "Neurocognitive outcomes and memory transfer in heart transplantation". [PDF]

Glob Cardiol Sci Pract
europepmc   +1 more source

Heart Transplantation Requiring Permanent Pacemaker: Risk Factors and Outcomes. [PDF]

J Clin Med
Keller M, Kwon YIC, Haghighi Y, Kasirajan V, Hashmi Z.   +4 more
europepmc   +1 more source

Characteristics Associated With Persistent Long COVID Symptoms in Healthcare Personnel Infected With SARS‐CoV‐2 Between August 2022 and May 2024: A Multicenter Cohort Analysis of US Healthcare Personnel

American Journal of Industrial Medicine, EarlyView.
ABSTRACT Background Long COVID affects a significant proportion of COVID‐19 survivors. This study examined persistent Long COVID symptoms among healthcare personnel (HCP) and evaluated associations with vaccination, prior SARS‐CoV‐2 infection, underlying health conditions, and demographics.
Eric Kontowicz, Amanda K. Irish, Lilly C. Lee, Howard A. Smithline, Ian D. Plumb, Melissa Briggs‐Hagen, Alexandra F. Rollins, Karisa K. Harland, Anusha Krishnadasan, Karin F. Hoth, Eliezer Santos‐León, David A. Talan, Nicholas M. Mohr, Project PREVENT Network   +13 more
wiley   +1 more source

Sex-specific association between body mass index and mortality after heart transplantation: A nationwide KOTRY Cohort Study. [PDF]

JHLT Open
Lee Y, Kim K, Kim AR, Hong JA, Hyun J, Lee SE, Kim MS, Jeon ES, Choi JO, Oh J, Kang SM, Kim MS, Kim JJ, Lee HY, Jung SH, KOTRY Study Group.   +15 more
europepmc   +1 more source

Systematic Cardiac Phenotyping of Patients With Copy Number Variants in the 15q11.2 Breakpoint 1 to Breakpoint 2 Region: A Retrospective Cohort Study From Nine Pediatric Cardiac Centers

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Microdeletions impacting 15q11.2 breakpoint (BP) 1 to BP2, adjacent to the Prader–Willi critical region, have previously described neuropsychiatric associations, with potential low penetrance presentations of congenital heart disease (CHD) also identified.
Morgan B. Wright, Maria B. Padua, Lindsey R. Helvaty, Kim L. McBride, Gabrielle Geddes, Vidu Garg, Seema R. Lalani, Stephanie Burns Wechsler, Jennelle C. Hodge, Benjamin J. Landis, Stephanie M. Ware   +10 more
wiley   +1 more source

Modeling the cost-effectiveness of introducing donation after controlled circulatory death for heart transplantation in France. [PDF]

Transpl Int
Atfeh J, Guerre P, Guihaire J, Sebbag L, Pozzi M, Huot L.   +5 more
europepmc   +1 more source

Translational Macrophage Mechano‐Immunotherapy for Next‐Generation Implantable Biomaterials

Advanced NanoBiomed Research, EarlyView.
This review explores how macrophage mechanosensing drives inflammation, fibrosis and foreign body responses to implanted biomaterials. It examines emerging pharmacological strategies to modulate mechanotransduction, alongside biomaterial platforms for localised drug delivery, clinical translation, regulatory considerations and standardised testing ...
Xueying Xu, Ian L. Chin, Richard P. Tan
wiley   +1 more source